Technical / White Paper
Discover the benefits of C3 Reduct®, Sabinsa’s new curcuminoid innovation!
Sabinsa’s C3 Reduct® is the only reductive metabolites of curcuminoids on the market to be approved as a Novel Food by EFSA. Easy to integrate into existing production processes and with the concentrated benefits of curcumin, C3 Reduct® has been shown to boost organ health and sports nutrition, and deliver a range of other targeted functionalities. Find out for yourself how C3 Reduct® can help you meet consumer health and wellness expectations – and open up new market opportunities.